Friday, July 9, 2021, 2 pm
Diabetic Foot Ulceration: Transcriptomic landscape
Aristidis Veves, Professor of Surgery at Harvard Medical School
Eugénia Carvalho, CNC
Dr. Aristidis Veves is the Rongxiang Xu, MD Professor of Surgery at Harvard Medical School. He is the Founding Director of the Rongxiang Xu, MD, Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center and the Research Director of the Joslin-Beth Israel Deaconess Foot Center. He received his M.D. from the Medical School, Aristotelion University of Thessaloniki (Greece) in 1981, his M.Sc. from the Faculty of Medicine, University of Manchester (U.K.) in 1991, and his D.Sc. from Athens Medical School (Greece) in 1993. Dr. Veves did his internship and residency in Greece. He then completed his Fellowship in Diabetes and Endocrinology at Manchester Royal Infirmary (U.K.) (1987-1993). In 1993 he moved to USA as a Research Fellow at Deaconess – Joslin Foot Center, Deaconess Hospital (Boston, MA) (1993-1995). He subsequently became Instructor (1995-1999), Assistant Professor (1999-2004) and Associate Professor (2004-2012) and Professor (2012-present).
Dr. Veves’ main academic interest is diabetes complications including regenerative medicine, foot ulceration and cardiovascular disease. He conducts basic, translational and clinical ‘bench to bedside’ research that is mainly funded by the National Institute of Health (NIH) and DARPA. The main aim of his research is to understand the pathogenesis of these complications and develop new therapeutic approaches.
Dr. Veves’ areas of expertise include wound healing, diabetic neuropathy, diabetic foot problems, and vascular reactivity.